GRACEcast ALL Subjects audio and video
ASCO Lung Cancer Highlights, Part 3: Immunotherapy for Stage III NSCLC (audio)
- Autor: Podcast
- Narrador: Podcast
- Editor: Podcast
- Duración: 0:08:40
- Mas informaciones
Informações:
Sinopsis
Dr. David Gerber, University of Texas-Southwestern, reviews results of the START trial of tecemotide immunotherapy for stage III unresectable NSCLC.
